Pregabalin sustained release tablet
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pregabalin sustained release tablet, covering 2016-08-16 to 2023-10-23. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain [Phase 4]